U.S. Medicare says no change to Alzheimer's drug restrictions

South Africa News News

U.S. Medicare says no change to Alzheimer's drug restrictions
South Africa Latest News,South Africa Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 97%

The U.S. government health plan for people over the age of 65 said it would not reconsider strict coverage limits put in place last year for new Alzheimer's treatments, rejecting a request from the Alzheimer's Association

The Centers for Medicare and Medicaid Services reaffirmed its policy allowing coverage for drugs designed to clear amyloid plaques from the brains of Alzheimer's patients only if a medication is approved under the Food and Drug Administration's standard review process, not under its accelerated review program.

The agency said it would also continue to require a registry to collect evidence of patient outcomes to reflect "real-world" care. The Alzheimer's Association said in a statement it "is appalled that the Biden Administration is extending its unjust decision to deny access to FDA-approved treatments for people living with Alzheimer's - a fatal disease."

The patient advocacy group estimated that for each day CMS leaves its policy in place, more than 2,000 individuals aged 65 or older may progress from mild dementia due to Alzheimer's to a more advanced stage of the disease at which they are no longer eligible for the new treatments.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

DNA Methylation Found to Play a Critical Role in Alzheimer's Disease, Say Mount Sinai ResearchersDNA Methylation Found to Play a Critical Role in Alzheimer's Disease, Say Mount Sinai ResearchersFindings from novel analytic approach could contribute to discovery of new therapeutic targets for Alzheimer's disease. Mount Sinai researchers have published a study today (February 22, 2023) in Alzheimer's & Dementia: The Journal of the Alzheimer's Association that sheds new light on the ro
Read more »

Social Security and Medicare: Here's where things stand for the 2 popular programsSocial Security and Medicare: Here's where things stand for the 2 popular programsHere's a breakdown of the dilemma, the potential fixes and the harsh politics around Social Security and Medicare.
Read more »

Social Security and Medicare: Troubling math, tough politicsSocial Security and Medicare: Troubling math, tough politicsHere's a breakdown of the dilemma, the potential fixes and the harsh politics around Social Security and Medicare.
Read more »

Social Security and Medicare: Here's where things stand for the 2 popular programsSocial Security and Medicare: Here's where things stand for the 2 popular programsHere's a breakdown of the dilemma, the potential fixes and the harsh politics around Social Security and Medicare.
Read more »



Render Time: 2025-03-03 13:42:43